Michael Anne Kyle,Lumumba Seegars,John M Benson et al.
Michael Anne Kyle et al.
Policy Points The private sector has large potential influence over social determinants of health, but we have limited information about how businesses perceive or engage in actions to promote health and well-being. We conducted a national ...
An Adaptive, Contextual, Technology-Aided Support (ACTS) System for Chronic Illness Self-Management [0.03%]
慢性病自我管理的自适应、情境化和技术辅助支持(ACTS)系统
Russell E Glasgow,Amy G Huebschmann,Alex H Krist et al.
Russell E Glasgow et al.
Policy Points Fundamental changes are needed in how complex chronic illness conditions are conceptualized and managed. Health management plans for chronic illness need to be integrated, adaptive, contextual, technology aided, patient driven...
Edward H Wagner
Edward H Wagner
Donald M Berwick
Donald M Berwick
Pharmaceutical Drugs of Uncertain Value, Lifecycle Regulation at the US Food and Drug Administration, and Institutional Incumbency [0.03%]
美国食品药品监督管理局的生命周期监管、不确定价值的药物和制度惯性效应
Matthew Herder
Matthew Herder
Policy Points The US Food and Drug Administration (FDA) has in recent years allowed onto the market several drugs with limited evidence of safety and effectiveness, provided that manufacturers agree to carry out additional studies while the...
Gail R Wilensky
Gail R Wilensky
FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis [0.03%]
美国食品与药物管理局的减钠目标与食品行业：有激励进行配方改良吗？微模拟成本效益分析
Brendan Collins,Chris Kypridemos,Jonathan Pearson-Stuttard et al.
Brendan Collins et al.
Policy Points The World Health Organization has recommended sodium reduction as a "best buy" to prevent cardiovascular disease (CVD). Despite this, Congress has temporarily blocked the US Food and Drug Administration (FDA) from implementing...
Opioid Use by Pregnant and Parenting Women: Let's Not Repeat the Mistakes of 25 Years Ago [0.03%]
孕期及产后妇女使用阿片类药物的情况：让我们不要重蹈25年前的覆辙
Harold A Pollack
Harold A Pollack
Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the "Need Clause" [0.03%]
少即是多：挪威的药物监管、抗生素政策和“需求条款”
Bård Hobaek,Anne Kveim Lie
Bård Hobaek
Policy Points The current crisis of antibiotic resistance calls for policy reforms locally and globally. Historical insight in different regulatory systems can inform current decision making. A strong regulatory control implementing antimic...
Jacob S Sherkow
Jacob S Sherkow